The company’s upcoming dividend and bonus issue, which the Board of Directors announced on October 31, 2025, coupled with the Q2FY26 results, have once again drawn investors to Dr. Lal Pathlabs.
Read Full
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
